What is Pfizer's investing cash flow?

Pfizer (PFE) reported investing cash flow of $785M in Q1 2026.

How has Pfizer's investing cash flow changed year-over-year?

Pfizer's investing cash flow decreased by 76.0% year-over-year, from $3.27B to $785M.

What is the long-term trend for Pfizer's investing cash flow?

Over 3 years (2021 to 2025), Pfizer's investing cash flow has grown at a -60.9% compound annual growth rate (CAGR), from -$22.55B to -$1.35B.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Pfizer PFE Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

Eli LillyLLY

-$3.92B-16.8%

Johnson & JohnsonJNJ

-$1.04B-250%

Merck & Co.MRK

-$10.21B-587%

AmgenAMGN

-$716M-60.2%

Ionis PharmaceuticalsIONS

$536.82M+215%

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$137.24B-0.4%

Enterprise value$199.91B+1.0%

P/E11.3×—

P/S2.2×0.0×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's investing cash flow?: Pfizer (PFE) reported investing cash flow of $785M in Q1 2026.
How has Pfizer's investing cash flow changed year-over-year?: Pfizer's investing cash flow decreased by 76.0% year-over-year, from $3.27B to $785M.
What is the long-term trend for Pfizer's investing cash flow?: Over 3 years (2021 to 2025), Pfizer's investing cash flow has grown at a -60.9% compound annual growth rate (CAGR), from -$22.55B to -$1.35B.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.